Mohammed Safi

Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis.

Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis.

Journal: Scientific reports

Published: December 30, 2024

Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells" [Phytomedicine 2021:91:153711].

Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells" [Phytomedicine 2021:91:153711].

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 13, 2024

Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.

Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.

Journal: Nature reviews. Clinical oncology

Published: December 06, 2024

High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma.

High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma.

Journal: Journal of inflammation research

Published: July 16, 2024

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.

Journal: Frontiers in immunology

Published: December 02, 2023

Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.

Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.

Journal: Global medical genetics

Published: August 11, 2023

Enhancers of mesenchymal stem cell stemness and therapeutic potency.

Enhancers of mesenchymal stem cell stemness and therapeutic potency.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 08, 2022

Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer.

Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer.

Journal: Frontiers in oncology

Published: November 24, 2022

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview.

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview.

Journal: Journal of inflammation research

Published: November 15, 2022

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study.

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study.

Journal: Cells

Published: October 08, 2022

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs).

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs).

Journal: Frontiers in pharmacology

Published: July 17, 2022

ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression.

ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression.

Journal: Journal of cellular and molecular medicine

Published: May 24, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026